• Home
  • About Us
  • Advisory board
  • Neurology
    • Alzheimer’s Disease
    • Epilepsy
    • Headache/Migraine
    • Movement Disorders
    • Multiple Sclerosis
    • Neuro-Oncology
    • Neuroradiology
    • Neurosurgery
    • Pain
    • Stroke
    • All Articles
    • All Videos
  • Psychiatry
    • Addiction
    • ADHD
    • Anxiety
    • Bipolar Disorder
    • Depression
    • Obesity
    • OCD
    • Psychosis
    • Schizophrenia
    • Sleep Disorders
    • All Articles
    • All Videos
  • CNS Journal
  • CME
  • Podcasts
    • All Podcasts
    • Navigating the PD universe
    • Reflections on Parkinson’s Disease
    • Parkinson Weekly
Neuropsychological Data Endorse Preclinical Alzheimer’s

Neuropsychological Data Endorse Preclinical Alzheimer’s

by Ket Patel | Aug 9, 2012 | All Articles For Neurology, Alzheimer's Disease

The first evidence of emerging Alzheimer’s disease surfaces at least 1 decade before the onset of the disorder, based on new neuropsychological data reported at the Alzheimer’s Association International Conference 2012. So far, though, there is no single test or...
Neuropsychological Data Endorse Preclinical Alzheimer’s

Nondrug Interventions Can Improve Dementia Patients’ Lives

by Ket Patel | Aug 8, 2012 | All Articles For Neurology, Alzheimer's Disease

Nonpharmacologic interventions bestow clinically meaningful benefits on patients with dementia, a literature review has concluded. But these aren’t one-size-fits-all activities, Dr. Clive Ballard said at the Alzheimer’s Association International Conference. Different...
Neuropsychological Data Endorse Preclinical Alzheimer’s

Psychosis in Alzheimer’s May Recur After Dropping Risperidone

by Ket Patel | Aug 7, 2012 | All Articles For Neurology, Alzheimer's Disease

When Alzheimer’s disease patients who took risperidone for psychoses discontinued the drug, they were more than four times more likely to relapse than were those who continued treatment in a randomized, placebo-controlled trial. The ADAD (Antipsychotic Discontinuation...
Neuropsychological Data Endorse Preclinical Alzheimer’s

Depression May Shorten Survival in Kidney Cancer

by Ket Patel | Aug 7, 2012 | All Articles For Psychiatry, Depression

Depression does more than strike at the heart; it can compromise survival for patients with metastatic kidney cancer. Researchers from the University of Texas M.D. Anderson Cancer Center in Houston found that patients with higher levels of cortisol – a stress hormone...
Neuropsychological Data Endorse Preclinical Alzheimer’s

Pretreatment ASPECTS Reading Affects Stroke Outcomes

by Ket Patel | Aug 4, 2012 | All Articles For Neurology, Stroke

Interim results from an ongoing study demonstrated that that a higher pretreatment Alberta Stroke Program Early CT Score on computed tomography angiogram images is associated with better outcome following endovascular therapy. “There is no standard imaging...
Page 138 of 168««...102030...137138139...150160...»»

Follow Us

  • Follow
  • Follow
  • Follow
  • Follow

Newsletter

Keep up to date with our latest
articles and journals

Subscribe

Oruen is the leading CNS medical publication and audio-visual platform committed to improving international communication and medical education for physicians with clinical interests in CNS medicine.

Navigation
  • Home
  • About Us
  • Advisory Board
  • CNS Journal
  • CME
  • Contact Us
Contact Oruen

Name: Dr. James Coe  (MD, PhD)

Editor

E-mail: Editor@oruen.com

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2026. Oruen LTD. All Rights Reserved. | Terms & Conditions | Privacy Policy | Sitemap

We use cookies to ensure that we give you the best experience on our website, please read our Privacy Policy before using this website.